Hereditary Cancer Testing Market by Diagnosis Type (Biopsy, Imaging and Others), By End-User (Hospitals, Clinics, and Diagnostic Centers), and by Region: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2024

Global hereditary cancer testing market expected to generate revenue of around USD 147.62 billion by end of 2024, growing at a CAGR of around 6% between 2018 and 2024. Hereditary cancer testing is a process that identifies an inherited gene mutation that increases the risk of cancer development. Hereditary cancer testing majorly covers predictive genetic testing and clinical DNA sequencing.

Request Brochure Request Discount

07-Aug-2018 | Number of pages: 110 | Report Code: ZMR-3262 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the hereditary cancer testing market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the hereditary cancer testing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the hereditary cancer testing market on a global level.

In order to give the users of this report a comprehensive view of the hereditary cancer testing market, we have included competitive landscape and analysis of Porter’s Five Forces model of the market. The study encompasses a market attractiveness analysis, where diagnosis type, end-user, and regional segmentation are benchmarked based on their market size, growth rate, and general attractiveness.

Global Hereditary Cancer Testing Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new product type launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market in global and regional basis.

The study provides a decisive view of the hereditary cancer testing market by segmenting the market based on diagnosis type, end-user, and regions. All the segments have been analyzed based on present and the future trends and the market is estimated from 2018 to 2024.

Based on diagnosis type, the hereditary cancer testing market is segmented as biopsy, imaging, and others. Based on end-user, the hereditary cancer testing market is segmented as hospitals, clinics, and diagnostic centers.

Growing demand for non-invasive techniques for detection of hereditary cancer coupled with government funding for improvement of rapid diagnostics and rising concerns of hereditary cancer are the major driving factors of hereditary cancer testing market. Difficulties in accessing the complete genomic data for early detection and prevention will influence the market growth during the forecast period.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further bifurcation into major countries including the U.S., Germany, France, U.K., China, Japan, India, and Brazil. This segment includes demand for hereditary cancer testing market based on individual segment and applications in all the regions and countries.

The report also includes detailed profiles of end players such as Myriad Genetics, Myogenes, Laboratory Corporation of America, Biocartis NV, Quest Diagnostics, Pathway Genomics, Invitae Corporation, and Strand Life Sciences Pvt. Ltd., among others.

This report segments the global hereditary cancer testing market as follows:

Global Hereditary Cancer Testing Market: by Diagnosis Type

  • Biopsy
  • Imaging
  • Others

Global Hereditary Cancer Testing Market: by End-User Channel

  • Hospitals
  • Clinics
  • Diagnostic Centers

Global Hereditary Cancer Testing Market: by Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports

Metastatic Bone Disease Market by Treatment (Medication, Radiation Therapy, Surgical Intervention, and Tumor Ablation Therapy), by Origin (Breast, Lung, Thyroid, Kidney, Prostate & Others), and by End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017- 2024

Jul-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3243 | Report Format:

The report covers forecast and analysis for the metastatic bone disease market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the metastatic bone dise...Read More

Blood Glucose Test Strips Market by Drug Technology (Channel Technology and Wicking Technology), By Sales Channels (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2024

Jul-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3239 | Report Format:

The report covers forecast and analysis for the blood glucose test strips market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the blood gluc...Read More

Active Wound Care Market by Product Type (Synthetic Skin Grafts, Allograft, Xenografts, Amniotic Tissue Grafts, Collagen Dressings, and Growth Factors); by Wound Type (Surgical Wounds, Ulcers [Pressure Ulcers, Diabetic Foot Ulcers, Arterial Ulcers, and Venous Ulcers], and Other Wounds), and by End Users (In-Patient Facilities and Out-Patient Facilities): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Jul-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3238 | Report Format:

The report covers forecast and analysis for the active wound care market on a global and regional level. The study provides historic data of 2017 along with a forecast from 2018 to 2024 based revenue (USD Million). The study includes drivers and restraints for the active wound care market along wi...Read More

Macrolide Drugs Market by Drug Type (14-membered ring agents, 14-membered ring agents, 15-membered ring agents (Azalides), 16-membered ring agents, and Ketolides), By Distribution Channels (Hospital pharmacies, Clinics, Hospitals, Retail pharmacies, and Online pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2024

Jul-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3230 | Report Format:

The report covers forecast and analysis for the macrolide drugs market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the macrolide drugs market along...Read More

Oncology Biosimilar Market by Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, and Others), By Drug Type (mAb, Immunomodulators, Hematopoietic Agents, G-CSF, and Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Jul-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3228 | Report Format:

The report covers forecast and analysis for the oncology biosimilar market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based revenue (USD Million). The study includes drivers and restraints for the oncology biosimilar...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.